These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Policy and procedure manual. Use of medications for indications, dosages and/or routes of administration not listed in the FDA literature. Curr Concepts Hosp Pharm Manage; 1988; 10(1):20. PubMed ID: 10317998 [No Abstract] [Full Text] [Related]
7. Procedure manual for drug monitoring in the Canadian hospital, approved by CSHP Council May 1978. Can J Hosp Pharm; 1979; 32(3):82-5, 87. PubMed ID: 10242860 [No Abstract] [Full Text] [Related]
8. Policy and procedure manual: nondiscrimination statement; drug samples, conduct, courtesy, and dress. Curr Concepts Hosp Pharm Manage; 1986; 8(1):18-9. PubMed ID: 10274960 [No Abstract] [Full Text] [Related]
9. Policy and procedure manual. Medical service representatives. Curr Concepts Hosp Pharm Manage; 1987; 9(2):19-20. PubMed ID: 10282080 [No Abstract] [Full Text] [Related]
13. Controlling investigational drug use in community hospitals. Chase PA. Am J Hosp Pharm; 1991 Jan; 48(1):61-2. PubMed ID: 2000874 [No Abstract] [Full Text] [Related]
15. ASHP guidelines for the use of investigational drugs in institutions. Am J Hosp Pharm; 1983 Mar; 40(3):449-51. PubMed ID: 6846357 [No Abstract] [Full Text] [Related]
17. Procedures for emergency or treatment use of investigational drugs. Klecker RJ, Cipolle RJ. Am J Hosp Pharm; 1987 May; 44(5):1086-9. PubMed ID: 3605118 [Abstract] [Full Text] [Related]
18. Ethical implications of withdrawal of experimental drugs at the conclusion of phase III trials. Roginsky MS, Handley A. Clin Res; 1978 Dec; 26(6):384-8. PubMed ID: 10239695 [No Abstract] [Full Text] [Related]